Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

A. J. M. Ferreri, K. Cwynarski, E. Pulczynski, C. P. Fox, E. Schorb, P. La Rosee, M. Binder, A. Fabbri, V. Torri, E. Minacapelli, M. Falautano, F. Ilariucci, A. Ambrosetti, A. Roth, C. Hemmaway, P. Johnson, K. M. Linton, T. Pukrop, J. Sonderskov Gorlov, M. BalzarottiG. Hess, U. Keller, S. Stilgenbauer, J. Panse, A. Tucci, L. Orsucci, F. Pisani, A. Levis, S. W. Krause, H. J. Schmoll, B. Hertenstein, M. Rummel, J. Smith, M. Pfreundschuh, G. Cabras, F. Angrilli, M. Ponzoni, M. Deckert, L. S. Politi, J. Finke, M. Reni, F. Cavalli, E. Zucca, G. Illerhaus, International Extranodal Lymphoma Study Group (IELSG)

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences